|
326
|
825
|
1wutA |
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes |
|
329
|
825
|
1wuyA |
Crystallographic studies on acyl ureas, a new class of inhibitors of glycogen phosphorylase. broad specificity of the allosteric site |
|
331
|
826
|
1ww2A |
Crystallographic studies on two bioisosteric analogues, n-acetyl-beta-d-glucopyranosylamine and n-trifluoroacetyl-beta-d-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase |
|
332
|
825
|
1wv0A |
Crystallographic studies on acyl ureas, a new class of inhibitors of glycogen phosphorylase. broad specificity of the allosteric site |
|
327
|
825
|
1wv1A |
Crystallographic studies on acyl ureas, a new class of inhibitors of glycogenphosphorylase. broad specificity of the allosteric site |
|
335
|
825
|
1xc7A |
Binding of beta-d-glucopyranosyl bismethoxyphosphoramidate to glycogen phosphorylase b: kinetic and crystallographic studies |
|
327
|
826
|
1uzuA |
Glycogen phosphorylase b in complex with indirubin-5'-sulphonate |
|
316
|
796
|
1qm5A |
Phosphorylase recognition and phosphorylysis of its oligosaccharide substrate: answers to a long outstanding question |
|
312
|
827
|
1pygA |
Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate |
|
334
|
826
|
1p2dA |
Crystal structure of glycogen phosphorylase b in complex with beta cyclodextrin |
|
333
|
825
|
1p2bA |
Crystal structure of glycogen phosphorylase b in complex with maltoheptaose |
|
338
|
825
|
1p4jA |
Crystal structure of glycogen phosphorylase b in complex with c-(1-hydroxy-beta-d-glucopyranosyl)formamide |
|
344
|
825
|
1p4hA |
Crystal structure of glycogen phosphorylase b in complex with c-(1-acetamido-alpha-d-glucopyranosyl) formamide |
|
342
|
825
|
1p4gA |
Crystal structure of glycogen phosphorylase b in complex with c-(1-azido-alpha-d-glucopyranosyl)formamide |
|
331
|
825
|
1p2gA |
Crystal structure of glycogen phosphorylase b in complex with gamma cyclodextrin |
|
333
|
825
|
1p29A |
Crystal structure of glycogen phosphorylase b in complex with maltopentaose |
|
329
|
831
|
1nojA |
Complex of glycogen phosphorylase with a transition state analogue nojirimycin tetrazole and phosphate in the t state |
|
330
|
828
|
1noiA |
Complex of glycogen phosphorylase with a transition state analogue nojirimycin tetrazole and phosphate in the t and r states |
|
337
|
831
|
1nokA |
Complex of glycogen phosphorylase with a transition state analogue nojirimycin tetrazole and phosphate in the t state |
|
324
|
834
|
1lwnA |
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 a resolution |
|
342
|
796
|
1l5vA |
Crystal structure of the maltodextrin phosphorylase complexed with glucose-1-phosphate |
|
322
|
834
|
1lwoA |
Crystal structure of rabbit muscle glycogen phosphorylase a in complex with a potential hypoglycaemic drug at 2.0 a resolution |
|
336
|
796
|
1l6iA |
Crystal structure of the maltodextrin phosphorylase complexed with the products of the enzymatic reaction between glucose-1-phosphate and maltopentaose |
|
327
|
808
|
1l7xA |
Human liver glycogen phosphorylase b complexed with caffeine, n-acetyl-beta-d-glucopyranosylamine, and cp-403,700 |
|
341
|
796
|
1l5wA |
Crystal structure of the maltodextrin phosphorylase complexed with the products of the enzymatic reaction between glucose-1-phosphate and maltotetraose |
|
334
|
809
|
1l5qA |
Human liver glycogen phosphorylase a complexed with caffeine, n-acetyl-beta-d-glucopyranosylamine, and cp-403700 |
|
336
|
810
|
1l5sA |
Human liver glycogen phosphorylase complexed with uric acid, n-acetyl-beta-d-glucopyranosylamine, and cp-403,700 |
|
332
|
825
|
1k08A |
Crystallographic binding study of 10 mm n-benzoyl-n'-beta-d-glucopyranosyl urea to glycogen phosphorylase b |
|
331
|
825
|
1k06A |
Crystallographic binding study of 100 mm n-benzoyl-n'-beta-d-glucopyranosyl urea to glycogen phosphorylase b |
|
331
|
830
|
1hlfA |
Binding of glucopyranosylidene-spiro-thiohydantoin to glycogen phosphorylase b: kinetic and crystallographic stud |
|
326
|
808
|
1l5rA |
Human liver glycogen phosphorylase a complexed with riboflavin, n-acetyl-beta-d-glucopyranosylamine and cp-403,700 |
|
307
|
828
|
1gpaA |
Structural mechanism for glycogen phosphorylase control by phosphorylation and amp |
|
322
|
828
|
1gpyA |
Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to t state glycogen phosphorylase b |
|
328
|
830
|
1gg8A |
Design of inhibitors of glycogen phosphorylase: a study of alpha-and beta-c-glucosides and 1-thio-beta-d-glucose compounds |
|
336
|
825
|
1h5uA |
The 1.76 a resolution crystal structure of glycogen phosphorylase b complexed with glucose and cp320626, a potential antidiabetic drug |
|
326
|
825
|
1gfzA |
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site |
|
332
|
830
|
1ggnA |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
317
|
823
|
1gpbA |
Glycogen phosphorylase b: description of the protein structure |
|
330
|
830
|
1ftyA |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
330
|
830
|
1fu7A |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
327
|
830
|
1ftqA |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
333
|
830
|
1ftwA |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
330
|
830
|
1fu4A |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
327
|
830
|
1fs4A |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
331
|
830
|
1fu8A |
Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design |
|
317
|
834
|
1fa9A |
Human liver glycogen phosphorylase a complexed with amp |
|
326
|
809
|
1fc0A |
Human liver glycogen phosphorylase complexed with n-acetyl-beta-d-glucopyranosylamine |
|
325
|
809
|
1em6A |
Human liver glycogen phosphorylase a complexed with glcnac and cp-526,423 |
|
330
|
834
|
1e1yA |
Flavopiridol inhibits glycogen phosphorylase by binding at the inhibitor site |
|
297
|
796
|
1e4oA |
Phosphorylase recognition and phosphorolysis of its oligosaccharide substrate: answers to a long outstanding question |
